Clinical trial
Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs
NCT04943588 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs
- Lead sponsor
- Queen Mary University of London
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 1, 2021
- Completion date
- January 30, 2026
- Enrollment
- 25,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.